These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33888325)

  • 21. Second generation inactivated eastern equine encephalitis virus vaccine candidates protect mice against a lethal aerosol challenge.
    Honnold SP; Bakken RR; Fisher D; Lind CM; Cohen JW; Eccleston LT; Spurgers KB; Maheshwari RK; Glass PJ
    PLoS One; 2014; 9(8):e104708. PubMed ID: 25116127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
    Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
    Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine.
    Pittman PR; Makuch RS; Mangiafico JA; Cannon TL; Gibbs PH; Peters CJ
    Vaccine; 1996 Mar; 14(4):337-43. PubMed ID: 8744562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A field study of persistence of antibodies in California horses vaccinated against western, eastern, and Venezuelan equine encephalomyelitis.
    Vanderwagen LC; Pearson JL; Franti CE; Tamm EL; Riemann HP; Behymer DE
    Am J Vet Res; 1975 Nov; 36(11):1567-71. PubMed ID: 1190598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses.
    Hu WG; Steigerwald R; Kalla M; Volkmann A; Noll D; Nagata LP
    Vaccine; 2018 Aug; 36(34):5194-5203. PubMed ID: 30037666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CpG/Poly (I:C) mixed adjuvant priming enhances the immunogenicity of a DNA vaccine against eastern equine encephalitis virus in mice.
    Ma J; Wang H; Zheng X; Xue X; Wang B; Wu H; Zhang K; Fan S; Wang T; Li N; Zhao Y; Gao Y; Yang S; Xia X
    Int Immunopharmacol; 2014 Mar; 19(1):74-80. PubMed ID: 24440303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large-Scale Complete-Genome Sequencing and Phylodynamic Analysis of Eastern Equine Encephalitis Virus Reveals Source-Sink Transmission Dynamics in the United States.
    Tan Y; Lam TT; Heberlein-Larson LA; Smole SC; Auguste AJ; Hennigan S; Halpin RA; Fedorova N; Puri V; Stockwell TB; Shilts MH; Andreadis T; Armstrong PM; Tesh RB; Weaver SC; Unnasch TR; Ciota AT; Kramer LD; Das SR
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation.
    Pandya J; Gorchakov R; Wang E; Leal G; Weaver SC
    Vaccine; 2012 Feb; 30(7):1276-82. PubMed ID: 22222869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses.
    Phillips AT; Schountz T; Toth AM; Rico AB; Jarvis DL; Powers AM; Olson KE
    J Virol; 2014 Feb; 88(3):1771-80. PubMed ID: 24257615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eastern equine encephalitis virus in mice I: clinical course and outcome are dependent on route of exposure.
    Honnold SP; Mossel EC; Bakken RR; Fisher D; Lind CM; Cohen JW; Eccleston LT; Spurgers KB; Erwin-Cohen R; Bradfute SB; Maheshwari RK; Glass PJ
    Virol J; 2015 Sep; 12():152. PubMed ID: 26420265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel vaccination approaches against equine alphavirus encephalitides.
    Carossino M; Thiry E; de la Grandière A; Barrandeguy ME
    Vaccine; 2014 Jan; 32(3):311-9. PubMed ID: 24295803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody studies in ponies vaccinated with Venezuelan equine encephalomyelitis (strain TC-83) and other alphavirus vaccines.
    Ferguson JA; Reeves WC; Hardy JL
    Am J Vet Res; 1977 Apr; 38(4):425-30. PubMed ID: 851275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational design of a live-attenuated eastern equine encephalitis virus vaccine through informed mutation of virulence determinants.
    Trobaugh DW; Sun C; Dunn MD; Reed DS; Klimstra WB
    PLoS Pathog; 2019 Feb; 15(2):e1007584. PubMed ID: 30742691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endemic eastern equine encephalitis in the Amazon region of Peru.
    Aguilar PV; Robich RM; Turell MJ; O'Guinn ML; Klein TA; Huaman A; Guevara C; Rios Z; Tesh RB; Watts DM; Olson J; Weaver SC
    Am J Trop Med Hyg; 2007 Feb; 76(2):293-8. PubMed ID: 17297038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralising antibodies for Mayaro virus in Pantanal, Brazil.
    Pauvolid-Corrêa A; Juliano RS; Campos Z; Velez J; Nogueira RM; Komar N
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):125-33. PubMed ID: 25742272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current strategic thinking for the development of a trivalent alphavirus vaccine for human use.
    Wolfe DN; Heppner DG; Gardner SN; Jaing C; Dupuy LC; Schmaljohn CS; Carlton K
    Am J Trop Med Hyg; 2014 Sep; 91(3):442-50. PubMed ID: 24842880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimeric alphavirus vaccine candidates for chikungunya.
    Wang E; Volkova E; Adams AP; Forrester N; Xiao SY; Frolov I; Weaver SC
    Vaccine; 2008 Sep; 26(39):5030-9. PubMed ID: 18692107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.
    Paulke-Korinek M; Kollaritsch H; Kundi M; Zwazl I; Seidl-Friedrich C; Jelinek T
    Vaccine; 2015 Jul; 33(30):3600-4. PubMed ID: 26036947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aerosol infection of Balb/c mice with eastern equine encephalitis virus; susceptibility and lethality.
    Phelps AL; O'Brien LM; Eastaugh LS; Davies C; Lever MS; Ennis J; Zeitlin L; Nunez A; Ulaeto DO
    Virol J; 2019 Jan; 16(1):2. PubMed ID: 30611287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive mapping of common immunodominant epitopes in the eastern equine encephalitis virus E2 protein recognized by avian antibody responses.
    Sun E; Zhao J; Sun L; Xu Q; Yang T; Qin Y; Wang W; Wei P; Sun J; Wu D
    PLoS One; 2013; 8(7):e69349. PubMed ID: 23922704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.